Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-05
2010-11-02
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S335500, C548S336100, C548S337100
Reexamination Certificate
active
07825150
ABSTRACT:
Methods and compositions for treating immunological and inflammatory diseases and disorders are disclosed. Particular methods and compositions comprise the administration of an agent that inhibits S1P lyase activity and at least one additional immunosuppressive and/or anti-inflammatory agent.
REFERENCES:
patent: 3968120 (1976-07-01), Regel
patent: 4567194 (1986-01-01), Kroeplien
patent: 4614662 (1986-09-01), Ramaswamy
patent: 5519040 (1996-05-01), Chow
patent: 5561134 (1996-10-01), Spada
patent: 5668161 (1997-09-01), Talley
patent: 5716929 (1998-02-01), Bemis
patent: 5843971 (1998-12-01), Boar
patent: 6100264 (2000-08-01), Aloup
patent: 6147097 (2000-11-01), Sugimoto
patent: 6180650 (2001-01-01), Frenette
patent: 6420522 (2002-07-01), Bemis
patent: 6518259 (2003-02-01), Holoshitz
patent: 6624188 (2003-09-01), Chandraratna
patent: 6692960 (2004-02-01), Bennett
patent: 6720320 (2004-04-01), Nishiyama
patent: 6743919 (2004-06-01), Koya
patent: 6997961 (2006-02-01), Chassot
patent: 7041291 (2006-05-01), Saba
patent: 7169390 (2007-01-01), Sabbadini
patent: 7265137 (2007-09-01), Sakuma
patent: 7649098 (2010-01-01), Augeri
patent: 2004/0039202 (2004-02-01), Sauter
patent: 2005/0221346 (2005-10-01), Saba
patent: 2005/0250794 (2005-11-01), Napper
patent: 2006/0019952 (2006-01-01), Distefano
patent: 2007/0154428 (2007-07-01), Sato
patent: 2007/0208063 (2007-09-01), Augeri et al.
patent: 2008/0262241 (2008-10-01), Wu
patent: 2009/0298901 (2009-12-01), Wu
patent: 04205081 (1993-08-01), None
patent: 08151386 (1996-06-01), None
patent: WO 93/06118 (1993-04-01), None
patent: WO 93/14752 (1993-08-01), None
patent: WO 97/46543 (1997-12-01), None
patent: WO 01/89460 (2001-11-01), None
patent: WO 03/028637 (2003-04-01), None
patent: WO 2004/071509 (2004-08-01), None
patent: WO 2005/075468 (2005-08-01), None
patent: WO 2006/135862 (2006-12-01), None
Nakajima, Modern Rheumatology, 2006, Springer Japan, vol. 16, pp. 269-275.
Chaudhuri et. al., Journal of the Royal Society of Medicine, 2005, Royal Society of Medicine, vol. 98, pp. 303-306.
Monien et. al., Expert Reviews in Neurotherapeutics, 2006, Expert Reviews Ltd, vol. 6(9), pp. 1293-1306.
Artavanis-Tsakonas et. al., Clinical & Experimental Immunology, 2003, British Society of Immunology, vol. 133, pp. 145-152.
Aboody et. al., PLOS ONE, 2006, Public Library of Science, vol. 1, issue 1, pp. 1-10.
Choi et. al., The Lancet, 2002, Williams & Wilkins, vol. 359, pp. 1173-1177.
Uetrecht, Toxicology, 1997, Elsevier Science, vol. 119, pp. 37-43.
Debandt et. al., Clinical Rheumatology, 2003, International League of Associations for Rheumatology, vol. 22, pp. 56-61.
Sicotte et. al., Neurology, 2001, AAN Enterprises, vol. 57, No. 10, pp. 1885-1888.
U.S. Appl. No. 12/628,309, filed Dec. 1, 2009, Augeri.
Cliff and Pyne,J. Org. Chem., 62: 1023-1032 (1997).
Cliff and Pyne,Tett. Letters, 36(33): 5969-5972 (1995).
Gobin and Phillips,Clin. Exp. Immunol., 85(2): 335-40 (1991).
Gugasyan et al.,Immunology Letters, 58: 133-138 (1997).
Halweg and Buchi,J. Org. Chem., 50(7): 1134-6 (1985).
HLA,Science, 309: 1682-3 (2005).
Houben et al.,Food Chem. Toxicol., 30(5): 427-30 (1992).
Houben et al.,Food Chem. Toxicol., 30(9): 749-57 (1992).
Jousserandot, Anne, et al.,Biochemistry37:17179-17191 (1998).
Pyne, Stephen G.,ACGC Chem. Res. Comm. 11:108-112 (2000).
Pyne and Pyne,Biochem. J., 349:385-402 (2000).
Pyne and Ung,Synlett, 280-282 (1998).
Schwab et al.,Science, 309:1735-1739 (2005).
Sweeny et al.,J. Org. Chem., 50:1133-1134 (1985).
Ung and Pyne,Tetrahedron: Asymmetry, 9:1395-1407 (1998).
Ung and Pyne,Tetrahedron Letters, 37(34):6209-6212 (1996).
Search Report and Written Opinion for Corresponding International Application PCT/US2008/075320 , dated Apr. 12, 2008.
Bachrach Max
Lexicon Pharmaceuticals, Inc.
Padmanabhan Sreeni
Pihonak Sarah
LandOfFree
Compositions and methods for treating immunological and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating immunological and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating immunological and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4239459